Pharmaceutical Technology

DECEMBER 12, 2022

In this last 2022 edition of the series, which started in June , Pharmaceutical Technology is tracking major trial announcements and decisions by regulators and reimbursement agencies that have occurred since mid-October, as well as their potential impact on manufacturing plans. Source: GlobalData Pharmaceutical Intelligence Center.

Packaging 59

Packaging Vaccines Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

JULY 14, 2022

Pharmaceutical companies regularly outsource different steps of drug manufacturing processes like parenteral manufacturing and packaging, solid dose, and small molecule or biologic active pharmaceutical ingredient (API) production, among others. Covid-19 vaccines stay in the spotlight.

Vaccines 52

Vaccines Packaging FDA Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 30, 2022

Crossing the approval hurdle for a new drug is a big milestone for pharmaceutical companies. Each month, Pharmaceutical Technology takes a look at recent decisions taken by regulatory and reimbursement agencies and identifies the key manufacturing players that can be impacted by them. Regulatory decisions come in.

Packaging 52

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

NOVEMBER 27, 2022

To combat such challenges, pharmaceutical companies need to adopt processes that are not just efficient, but agile. Empowering labs with automated equipment that produces rich, traceable, and actionable data insights means pharmaceutical companies can ensure drug production runs smoothly – even under stress.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

pharmaphorum

AUGUST 16, 2021

Nearly every element of the clinical trial design, data collection, analysis and approvals has been shortened and this helped ensure the swift rollout of safe and effective vaccines.”. To this end, ryze has been used extensively in several COVID-19 vaccine trials, to reduce the lag time for SDTM conversions. About the interviewee.

Documentation 98

Documentation Vaccines Packaging Pharmaceutical Companies 98

Roots Analysis

OCTOBER 30, 2023

The next generation RNA therapeutics and RNA vaccines pipeline currently features the presence of more than 20 circular RNA therapeutics and vaccines, being developed across initial stages of drug development (discovery and preclinical).

Vaccines 40

Vaccines Immunization Packaging Pharmaceutical Companies 40

Viseven

SEPTEMBER 14, 2023

For example, a pharmaceutical brand can face increased acquisition costs if a supplier has not delivered on time. It also bears extra replacement expenses when drugs are discarded due to improper packaging. Technologies allow pharmaceutical companies to collect and analyze a massive amount of data to ensure proper drug safety.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Pharmacy Procurement 52

Pharmaceutical Technology

DECEMBER 9, 2022

Pharmaceutical Technology Excellence Rankings – The Verdict. Solvias is a Swiss-based pharmaceutical company focused on contract research, development and manufacturing. The company is ranked in the M&A, PRODUCT LAUNCHES and RESEARCH AND DEVELOPMENT categories in the 2022 Pharmaceutical Technology Excellence Rankings.

Vaccines 52

Vaccines Compounding FDA Packaging 52

Pharmaceutical Technology

NOVEMBER 15, 2022

When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. An example is the ability of a patient suffering from venous thrombosis to perform their own injections of heparin – an anticoagulant often packaged in a prefilled syringe.

Packaging 52

Packaging Vaccines Compounding Dosage 52

PharmaShots

MARCH 9, 2023

Other Affiliations: Angela is an active Board of Director member of the Pfizer Foundation (a charitable organization addressing global health challenges), European Federation of Pharmaceutical Industries and Associations (EFPIA), and UPS (the global leader in package delivery and supply chain logistics).

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

pharmaphorum

MAY 26, 2022

Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening. Vaccines approved for public use require comprehensive RCTs to establish their safety and efficacy. About the authors.

Packaging 143

Packaging Vaccines Generic Medicine Compounding 143

Pharmaceutical Technology

DECEMBER 15, 2022

The Singapore Government has launched Biologics Pharma Innovation Programme Singapore (BioPIPS), which aims to increase the country’s manufacturing capacity for biologics, including recombinant proteins and vaccines. The organizations plan to use data analytics to improve manufacturing processes. Additionally, Merck & Co.

Vaccines 105

Vaccines Packaging Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MARCH 22, 2023

In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. The European Commission plans to launch its revised EU pharmaceutical package in Q1 2023 to ease drug shortages,” she says.

Packaging 105

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

JANUARY 22, 2021

” Generic and opioid-alternative companies could benefit from expanded coverage, if Biden changes policy, according to analysts at Jefferies. What this means for the pharma industry is likely business as usual, at least until the midterm elections in 2022.” ” Science first.

Packaging 63

Packaging Pharmaceutical Companies Pharmaceutical Companies Vaccines 63